InsidersTradesSigma
Follow the 东星医疗 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 东星医疗 has published 4 insider filings. Market capitalisation: €2.6bn. The latest transaction was reported on 7 January 2025 (Purchase). Among the most active insiders: 龚爱琴. All data is free.
4
Insider Decl.
n/a
Thresholds
€31,861
4 ops.
Buy Volume
n/a
n/a
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,283 of 29,063 companies
33.2
score / 100
Value37
Quality29
FCF yld1.5%
Earn yld-1.5%
EV/EBITDA·
ROE-1.5%
Gross mgn49%
Net mgn-9.8%
Debt/EBITDA7.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 January 2025
Acerca de 东星医疗
东星医疗 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se centra en el desarrollo y suministro de soluciones médicas innovadoras.